Finalisation of disposal of 100% shareholding in Adcock Ingram Healthcare Private Limited Adcock Ingram Holdings Limited Incorporated in the Republic of South Africa (Registration number 2007/016236/06) Share code: AIP ISIN: 000123436 (“Adcock”) FINALISATION OF DISPOSAL OF 100% SHAREHOLDING IN ADCOCK INGRAM HEALTHCARE PRIVATE LIMITED (the selling and marketing operation in India) 1. Introduction Adcock shareholders are referred to the announcement released on the Stock Exchange News Service of the JSE Limited on 6 April 2016, regarding its wholly-owned subsidiaries, Adcock Ingram International (Pty) Limited and Adcock Ingram Healthcare (Pty) Limited (“Sellers”) entering into definitive agreements with Samara Capital Partners Fund II Limited for the disposal of their entire 100% shareholding in Adcock Ingram Healthcare Private Limited (“Adcock Healthcare”) which operates its Indian pharmaceutical marketing and selling business (“Transaction”). 2. Finalisation of the Transaction Adcock can confirm that all conditions precedent to the Transaction have been fulfilled or waived and the closing date of the Transaction is Friday, 14 October 2016. The Regulatory Services Business has been separated from Adcock Healthcare as of 31 August 2016 and is now housed in a new subsidiary named Relicare Tech Services Private Limited. 3. Sale consideration The total sale consideration received by the Sellers pursuant to the Transaction is ZAR 407 million on the basis as set out below: a) Proceeds from buy-back of shares in Adcock Healthcare of INR 400 million (ZAR 85 million) which was a condition precedent to the Transaction; and b) Disposal proceeds of INR 1,522 million (ZAR 322 million). Johannesburg 14 October 2016 Investment Bank, Financial Advisor and JSE Sponsor to Adcock RAND MERCHANT BANK (A division of FirstRand Bank Limited) International Legal Counsel to Adcock Cyril Amarchand Mangaldas South African Legal Counsel to Adcock Edward Nathan Sonnenbergs Inc. 1 Date: 14/10/2016 05:25:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.